Literature DB >> 72579

Surgery, venous thrombosis and anti-Xa.

J D Stamatakis, D Lawrence, V V Kakkar.   

Abstract

Deep venous thrombosis is a common and unpredictable complication of surgery. In this study it is proposed that patients who develop this complication may be predicted by a low preoperative level of a naturally occurring inhibitor of coagulation, anti-Xa. Two groups of patients were investigated. Women taking the oral contraceptive pill had lower preoperative anti-Xa levels than their non-pill controls (P less than 0.01) and in addition had a significantly higher incidence of deep venous thrombosis (DVT) following emergency surgery (P less than 0.05). In 90 patients undergoing total hip replacement, the mean preoperative anti-Xa level of those patients who developed DVT was significantly lower than those who did not (P less than 0.001). Ninety-four per cent of patients with a preoperative anti-Xa level of less than 80 per cent developed DVT. The effect of low dose heparin on anti-Xa was studied. The results suggest a mechanism for the cause of postoperative thrombosis which also permits selection of individual patients who will develop this complication.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 72579     DOI: 10.1002/bjs.1800641007

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  3 in total

1.  Trends in the content and use of oral contraceptives in the United States, 1964-88.

Authors:  B B Gerstman; T P Gross; D L Kennedy; R C Bennett; D K Tomita; B V Stadel
Journal:  Am J Public Health       Date:  1991-01       Impact factor: 9.308

2.  Deep venous thromboembolism in patients undergoing inguinal lymph node dissection for melanoma.

Authors:  J M Arbeit; S F Lowry; B R Line; D C Jones; M F Brennan
Journal:  Ann Surg       Date:  1981-11       Impact factor: 12.969

3.  Preoperative antithrombin III activities and lipoprotein concentrations as predictors of venous thrombosis in patients with fracture of neck of femur.

Authors:  J H Winter; A Fenech; B Bennett; A S Douglas
Journal:  J Clin Pathol       Date:  1983-05       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.